참고문헌 (39)

1. Kang H-Y, Ko S-K, Liew D. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions. Clin Ther 2009;31(12):2919-30. 

   상세보기

2. Kim HC, Cho SMJ, Lee H, et al. Korea hypertension fact sheet 2020: analysis of nationwide population-based data. Clin Hypertens 2021;27(1):1-4. 

   상세보기

3. Lee J-H, Kim K-I, Cho M-C. Current status and therapeutic considerations of hypertension in the elderly. Korean J Intern Med 2019;34(4):687. 

   상세보기

4. Youn HM, Lee HJ, Park E-C. Position value for relative comparison of healthcare status of Korea in 2018. Health Policy Manag 2021;31(2): 217-24. 

   원문보기 상세보기

5. Lee H-Y, Shin J, Kim G-H, et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens 2019;25(1):1-24. 

   상세보기

6. Flack JM, Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med 2020;30(3):160-4. 

   상세보기

7. Moriarty F, Bennett K, Fahey T. Fixed-dose combination antihypertensives and risk of medication errors. Heart 2019;105(3):204-9. 

   상세보기

8. Gradman AH, Basile JN, Carter BL, Bakris GL; American Society of Hypertension Writing Group. Combination therapy in hypertension. J Am Soc Hypertens 2010;4(2):90-8. 

   상세보기

9. Kim SH, Shin DW, Kim S, et al. Prescribing patterns of antihypertensives for treatment-naive patients in South Korea: from Korean NHISS claim data. Int J Hypertens 2019;2019:4735876. 

10. Takahashi Y, Ishizaki T, Nakayama T, Kawachi I. Social network analysis of duplicative prescriptions: One-month analysis of medical facilities in Japan. Health Policy 2016;120(3):334-41. 

    상세보기

11. Lim CM, Aryani Md Yusof F, Selvarajah S, Lim TO. Use of ATC to describe duplicate medications in primary care prescriptions. Eur J Clin Pharmacol 2011;67(10):1035-44. 

    상세보기

12. Al Khaja KAJ, Ahmed Isa H, Veeramuthu S, Sequeira RP. Potentially inappropriate prescribing in older adults with hypertension or diabetes mellitus and hypertension in a primary care setting in Bahrain. Med Princ Pract 2018;27(3):241-9. 

    상세보기

13. Sohn H-S, Lee Y-S, Choi K-E, Shin HT. Analysis of frequent therapeutic duplication drug classes based on national health insurance claimed data in Korea. Korean J Clin Pharm 2010;20(3):262-7. 

14. Kim J, Park S, Kim H, Je NK. National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2 diabetes mellitus. Eur J Clin Pharmacol 2019;75(12):1723-30. 

    상세보기

15. Health insurance review & assessment service. Drug reimbursement list and table of upper limits. Available from https://www.hira.or.kr/bbsDummy.do?pgmidHIRAA030014050000&brdScnBltNo4&brdBltNo1622&pageIndex4. Accessed Oct 1, 2021. 

16. Choi HE, Lee JW, Je NK, Jeon KH. Use of SGLT2 inhibitor/metformin fixed dose combination in Korea. Korean J Clin Pharm 2022;32(1):13-9. 

    원문보기 상세보기

17. Shrestha PL, Shrestha PA, Vivo RP. Epidemiology of comorbidities in patients with hypertension. Curr Opin Cardiol 2016;31(4):376-80. 

    상세보기

18. Mohamed SF, Uthman OA, Caleyachetty R, et al. Uncontrolled hypertension among patients with comorbidities in sub-Saharan Africa: protocol for a systematic review and meta-analysis. Syst Rev 2020;9(1):1-5. 

    상세보기

19. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120(8):713-9. 

    상세보기

20. Gottwald-Hostalek U, Sun N, Barho C, Barho C, Hildemann S. Management of hypertension with a fixed-dose (single-pill) combination of bisoprolol and amlodipine. Clin Pharmacol Drug Dev 2017;6(1):9-18. 

    상세보기

21. Bramley DE. The ability of anaesthetists to identify generic medications from trade names. Anaesth Intensive Care 2009;37(4):624-9. 

    상세보기

22. Aronson JK. Medication errors resulting from the confusion of drug names. Expert Opin Drug Saf 2004;3(3):167-72. 

    

23. Korea Institute of Drug Safety & Risk Management. Therapeutic Duplication. Available from https://www.drugsafe.or.kr/iwt/ds/ko/useinfo/EgovDurInfoSerEff.do. Accessed May 15, 2022. 

24. Golchin N, Frank SH, Vince A, Isham L, Meropol SB. Polypharmacy in the elderly. J Res Pharm Pract 2015;4(2):85. 

    상세보기

25. Rambhade S, Chakarborty A, Shrivastava A, Patil UK, Rambhade A. A survey on polypharmacy and use of inappropriate medications. Toxicol Int 2012;19(1):68-73. 

    상세보기

26. Jokanovic N, Tan EC, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc 2015;16(6):535.e1-12. 

27. Cooper JA, Moriarty F, Ryan C, et al. Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria. Eur J Clin Pharmacol. 2016;72(5):583-91. 

    상세보기

28. Salazar JA, Poon I, Nair M. Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf 2007;6(6):695-704. 

    상세보기

29. Mason NA. Polypharmacy and medication-related complications in the chronic kidney disease patient. Curr Opin Nephrol Hypertens 2011;20(5):492-7. 

    상세보기

30. Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013;158(11):825-30. 

    상세보기

31. Zaman ZA, Kumari V. Comparison of the effects of amlodipine and cilnidipine on blood pressure, heart rate, proteinuria and lipid profile in hypertensive patients. Int J Basic Clin Pharmacol 2013;2(2):160-4. 

    상세보기

32. Vrettos I, Voukelatou P, Katsoras A, Theotoka D, Kalliakmanis A. Diseases linked to polypharmacy in elderly patients. Curr Gerontol Geriatr Res 2017;2017:4276047. 

33. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2021;42(36):3599-726. 

    상세보기

34. Lee I-H, Shim D-Y. Trends and appropriateness of outpatient prescription drug use in veterans. Korean J Clin Pharm 2018;28(2):107-16. 

    원문보기 상세보기

35. Health Insurance Review and Assessment Service. 2019 Drug reimbursement adequacy evaluation result. Available from https://www.hira.or.kr/cms/open/04/04/12/2020_9.pdf. Accessed May 15, 2022. 

36. Koo H, Lee MT, You SH, et al. Duplicated tramadol use in chronic low back pain: A nationwide cross-sectional study. Basic Clin Pharmacol Toxicol 2020;126(3):226-35. 

    상세보기

37. Korean law information center. Criteria for Special Cases concerning the Calculation of Partial Burden of Self-Employee. Available from https://www.law.go.kr/LSW//admRulInfoP.do?admRulSeq2100000207843&chrClsCd010201#AJAX. Accessed May 15, 2022. 

38. Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol 2010;10:16. 

    상세보기

39. Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS. Medication management at home: medication-related risk factors associated with poor health outcomes. Age Ageing 2005;34(6):626-32. 

    상세보기

저자의 다른 논문 :

정경혜 (10)